Time to Clinical Benefit of Dapagliflozin in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction: A Prespecified Secondary Analysis of the DELIVER Randomized Clinical Trial
Muthiah Vaduganathan, Brian L. Claggett, Pardeep Jhund, Rudolf A. De Boer, Adrian F. Hernandez, Silvio E. Inzucchi, Mikhail N. Kosiborod, Carolyn S.P. Lam, Felipe Martinez, Sanjiv J. Shah, Akshay S. Desai, Sheila M. Hegde, Daniel Lindholm, Magnus Petersson, Anna Maria Langkilde, John J.V. McMurray, Scott D. Solomon*
*Corresponding author for this work
Research output: Contribution to journal › Article › Academic › peer-review
23Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Time to Clinical Benefit of Dapagliflozin in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction: A Prespecified Secondary Analysis of the DELIVER Randomized Clinical Trial'. Together they form a unique fingerprint.